# How Does Red Light Therapy Work?

_Updated 2026-03-20_

Red light therapy works through photobiomodulation: photons at specific wavelengths (primarily 660nm and 850nm) penetrate the skin and are absorbed by cytochrome c oxidase in mitochondria. This triggers increased ATP production, reduced oxidative stress, and a cascade of cellular repair mechanisms that improve collagen synthesis, reduce inflammation, and accelerate tissue healing.

## What Is Photobiomodulation?

Photobiomodulation (PBM) is the scientific term for the biological process by which non-ionizing light — specifically in the red (620–700nm) and near-infrared (700–1100nm) spectrum — stimulates cellular function. Unlike ultraviolet light, which damages DNA, or infrared heat lamps, which simply warm tissue, PBM operates through a precise photochemical mechanism that has been validated in over 5,000 peer-reviewed studies.

The term was formally adopted by the World Association for Photobiomodulation Therapy in 2015 to replace older, less precise names like "low-level laser therapy" (LLLT) and "cold laser therapy." This distinction matters because PBM encompasses both laser and LED light sources, and the therapeutic effect depends on wavelength, dose, and tissue target — not the coherence of the light source.

At its core, PBM is an interaction between photons and chromophores — light-absorbing molecules within cells. The primary chromophore in human tissue is cytochrome c oxidase (CCO), a copper-containing enzyme embedded in the inner mitochondrial membrane. When photons at the correct wavelength strike CCO, they initiate a measurable increase in cellular energy production, as demonstrated by Karu (2010) in foundational research on mitochondrial photon absorption.

> **Key takeaway:** Photobiomodulation is a photochemical process where red and near-infrared light stimulates mitochondrial energy production — validated by over 5,000 peer-reviewed studies.

## How Photons Interact With Cells

When red or near-infrared photons enter the skin, they follow the principles of tissue optics. The epidermis, dermis, and subcutaneous layers each scatter and absorb light differently. Red light at 660nm penetrates approximately 2–3mm into tissue, reaching the dermal layer where fibroblasts reside. Near-infrared at 850nm penetrates deeper — up to 5–10mm — reaching muscle, nerve, and joint tissue beneath the skin surface.

The key to understanding red light therapy is the "optical window" — a wavelength range between roughly 600nm and 1100nm where biological tissue is relatively transparent. Below 600nm, hemoglobin and melanin absorb most of the light before it reaches target cells. Above 1100nm, water absorption dominates. This optical window is why red and NIR wavelengths are therapeutically effective while other visible light colors are not.

Once photons reach their target chromophore (cytochrome c oxidase), the interaction is quantum-mechanical: a photon is absorbed, transferring its energy to the enzyme. This is not a thermal effect — the temperature increase is negligible. Instead, the absorbed photon energy causes a conformational change in CCO that releases nitric oxide (NO) from the enzyme's binding site, unblocking the electron transport chain and allowing ATP synthesis to resume at full capacity.

> **Key takeaway:** Red and near-infrared light exploit the biological "optical window" (600–1100nm) to reach mitochondria without thermal damage, triggering ATP synthesis through photon-enzyme interaction.

## The Cytochrome c Oxidase Mechanism

Cytochrome c oxidase (CCO), also known as Complex IV of the mitochondrial electron transport chain, is the primary photoacceptor for red and near-infrared light. Karu (2010) established that CCO has distinct absorption peaks at 620nm, 680nm, 760nm, and 820nm — corresponding precisely to the wavelengths that produce the strongest photobiomodulation effects in clinical studies.

Under normal conditions, nitric oxide (NO) competes with oxygen for binding at the CCO active site. When NO occupies this binding site, it effectively "poisons" the enzyme and reduces ATP output — a state associated with aging, chronic inflammation, and mitochondrial dysfunction. When photons at 660nm or 850nm are absorbed by CCO, they photodissociate the NO molecule, restoring oxygen binding and re-activating the electron transport chain.

This mechanism explains why photobiomodulation is particularly effective in stressed or damaged tissue: cells with impaired mitochondrial function have more NO-blocked CCO, meaning there is more "room for improvement." Healthy cells with normally functioning mitochondria show a smaller response — a phenomenon known as the Arndt-Schulz law, which underpins the biphasic dose-response curve observed across PBM research by Hamblin (2017).

> **Key takeaway:** Cytochrome c oxidase is the molecular target — red light displaces nitric oxide from the enzyme, restoring mitochondrial ATP production especially in stressed or aging cells.

## ATP Synthesis Cascade

Once cytochrome c oxidase is reactivated, the mitochondrial electron transport chain resumes full operation. The immediate result is a measurable increase in adenosine triphosphate (ATP) production — the cell's primary energy currency. Cheng et al. (1982) demonstrated that cellular energy stimulation can increase ATP concentrations by 300–500%, depending on dose and cell type.

This surge in ATP has downstream effects that explain the diverse clinical benefits of red light therapy. Increased ATP drives collagen and elastin synthesis in fibroblasts — directly relevant to skin rejuvenation. It powers the sodium-potassium pump, improving cellular hydration and membrane transport. It fuels DNA repair mechanisms, accelerates cell division, and supports the production of reactive oxygen species (ROS) at low, signaling-appropriate levels that activate NF-κB and other transcription factors.

The ATP cascade also modulates inflammation. By increasing cellular energy, PBM allows immune cells to complete their inflammatory response more efficiently, transitioning from pro-inflammatory (M1) to anti-inflammatory (M2) phenotypes faster. Hamblin (2017) showed that PBM reduces TNF-α, IL-1β, and IL-6 levels while increasing anti-inflammatory cytokine IL-10 — explaining the reduction in puffiness and dark circles observed in periorbital treatment studies.

> **Key takeaway:** The ATP cascade from photobiomodulation drives collagen synthesis, reduces inflammation, and accelerates cellular repair — explaining why one wavelength can address wrinkles, dark circles, and puffiness simultaneously.

## Wavelength Science: 660nm vs 850nm

The two most clinically validated wavelengths for photobiomodulation are 660nm (visible red) and 850nm (near-infrared). They serve complementary roles based on their penetration depth and tissue interaction. Red light at 660nm is strongly absorbed by cytochrome c oxidase and hemoglobin, making it optimal for superficial tissue targets: the epidermis and papillary dermis where fibroblasts and keratinocytes reside.

Mota et al. (2023) demonstrated that 660nm light specifically reduces periocular wrinkle volume by 31.6% in a randomized controlled trial of 137 participants — the largest RCT focused on periorbital rejuvenation to date. The mechanism is direct stimulation of dermal fibroblasts to increase type-I procollagen synthesis, as confirmed by Barolet (2009) showing a 31% increase in procollagen expression and simultaneous reduction in MMP-1 (the collagenase enzyme).

Near-infrared at 850nm penetrates deeper into tissue, reaching subcutaneous fat, muscle, and even bone. At the periorbital level, this means 850nm light reaches the orbicularis oculi muscle and the microvasculature responsible for dark circles and puffiness. Lee et al. (2007) showed that combined red and NIR wavelengths outperformed single-wavelength treatment, achieving 36% wrinkle reduction and 19% elasticity improvement — the scientific basis for dual-wavelength protocols used in advanced devices.

> **Key takeaway:** 660nm targets collagen-producing fibroblasts in the dermis (31.6% wrinkle reduction per Mota 2023), while 850nm penetrates deeper to reduce inflammation and improve microcirculation — together, they deliver synergistic results.

## The Dose-Response Relationship

One of the most important — and most misunderstood — aspects of red light therapy is the dose-response relationship. More is not better. Photobiomodulation follows a biphasic dose-response curve (also called the Arndt-Schulz law): low doses stimulate cellular function, while excessive doses can inhibit it. This is why clinical studies use precisely calibrated protocols rather than "maximum power" approaches.

Dose in photobiomodulation is measured in joules per square centimeter (J/cm²), calculated as irradiance (mW/cm²) multiplied by exposure time (seconds), divided by 1,000. The optimal dose range for skin rejuvenation is typically 3–6 J/cm², as established by Mota et al. (2023) using 3.8 J/cm² for periocular treatment. Going below 1 J/cm² produces no measurable effect; exceeding 10–15 J/cm² can trigger inhibitory responses that negate the benefits.

This biphasic relationship explains why many consumer devices either fail to produce results (insufficient irradiance) or produce inconsistent results (uncontrolled dose). Clinical-grade devices maintain consistent irradiance at the treatment surface, ensuring that the therapeutic dose window is achieved reliably. Avci et al. (2013), in the most-cited LLLT review in dermatology, emphasized that standardized dosimetry is the single most important factor separating effective from ineffective light therapy.

> **Key takeaway:** Photobiomodulation follows a biphasic dose curve — the therapeutic window is 3–6 J/cm² for skin, and both underdosing and overdosing reduce efficacy. Precise irradiance control is essential.

## FAQ

**How long does it take for red light therapy to work?**

Most clinical studies show measurable changes after 4–8 weeks of consistent daily use. Mota et al. (2023) demonstrated 31.6% wrinkle volume reduction after 10 sessions over 4 weeks. Cellular changes begin immediately, but visible results require cumulative collagen remodeling.

**Is red light therapy safe for eyes?**

Red light (660nm) and near-infrared (850nm) at therapeutic doses are not harmful to the retina. However, direct exposure to high-intensity LEDs should be avoided. Periorbital devices like Angel Acid are engineered with beam angles and irradiance levels specifically calibrated for safe use around the eye area.

**Does red light therapy actually increase collagen?**

Yes. Multiple peer-reviewed studies confirm this. Barolet (2009) measured a 31% increase in type-I procollagen expression with 660nm LED exposure. Wunsch & Matuschka (2014) confirmed intradermal collagen density increase via ultrasound measurement in a gold-standard RCT with 136 participants.

**What is the difference between red light therapy and infrared?**

Red light (620–700nm) is visible and primarily absorbed in the superficial dermis. Near-infrared (700–1100nm) is invisible and penetrates deeper into muscle, nerve, and joint tissue. Both work through the same mechanism — cytochrome c oxidase activation — but at different tissue depths.

**Can you use red light therapy every day?**

Yes, daily use within the recommended dose range (3–6 J/cm² for skin) is safe and clinically validated. Most studies showing positive results used daily or near-daily protocols. The key is consistent dose control, not extended exposure times.

**Why doesn't any LED light work the same way?**

Only specific wavelengths match the absorption spectrum of cytochrome c oxidase. White LEDs, blue LEDs, and even slightly off-target red LEDs (e.g., 630nm vs 660nm) do not deliver optimal photobiomodulation. Wavelength precision within ±5nm of the target peak is critical, as demonstrated by Karu (2010).

**Is red light therapy the same as a heat lamp?**

No. Heat lamps emit broad-spectrum infrared radiation (primarily above 1100nm) that warms tissue thermally. Red light therapy uses narrow-band wavelengths (660nm, 850nm) that trigger a photochemical — not thermal — reaction in mitochondria. The temperature increase from PBM is negligible.

**How deep does red light penetrate skin?**

Red light at 660nm penetrates approximately 2–3mm into tissue, reaching the dermis. Near-infrared at 850nm penetrates 5–10mm, reaching subcutaneous tissue, muscle, and bone. Penetration depth depends on wavelength, tissue type, and skin pigmentation.